According to Artiva Biotherapeutics's latest financial reports the company's current EPS (TTM) is -2,89ย โฌ. In 2024 the company made an earnings per share (EPS) of -4,97ย โฌ a decrease over its 2023 EPS that were of -1,02ย โฌ.